PaulAlfredGurbelMDFACC, FSCAI,FAHA

Cardiology • Baltimore, MD

Adult Congenital Heart Disease, Interventional Cardiology

Professor of Medicine, Johns Hopkins University Adjunct Professor of Medicine, Duke University

Join to view full profile

Dr. Gurbel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gurbel's full profile

Already have an account?

Office
2401 W. Belvedere Avenue
Sinai Center for Thrombosis Research and Drug Development Schapiro Bldg, South Tower, 2nd Floor
Baltimore, MD 21215
Phone+1 410-367-2590

Education & Training

Duke University HospitalFellowship, Cardiovascular Disease, 1987 - 1990
Duke University HospitalChief Residency, Internal Medicine, 1988 - 1989
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 1986 - 1987
Duke University HospitalResidency, Internal Medicine, 1983 - 1986
University of Maryland School of MedicineClass of 1983
Johns Hopkins UniversityBA, Natural Science, Phi Beta Kappa, 1975 - 1979

Certifications & Licensure

MD State Medical License 1986 - 2026
VA State Medical License 2015 - 2020
NC State Medical License 1987 - 1992
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

Best Doctors in Baltimore Baltimore Magazine
Best Doctors
Fellow AHA AHA
Distinguished Alumnus Award Johns Hopkins University, 2022
Doctor Honoris Causa Nicolaus Copernicus University, 2016
Alpha Omega Alpha 1982
Phi Beta Kappa 1978
Top Doctors:Baltimore Area Castle Connolly, 2012
Top Doctors:Washington-Baltimore Castle Connolly, 2012
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Fellow (FACC) American College of Cardiology
Join now to see all

Clinical Trials

Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin Start of enrollment: 2006 Mar 01
Unknown status
Phase 4
Flavonoid Effect on Activation and Stimulation of Thrombocytes, hsCRP and Lipid Profile Start of enrollment: 2006 Sep 01
Completed
Not Applicable
Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI) Start of enrollment: 2010 Jul 01
Terminated
Not Applicable
Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis Start of enrollment: 2010 Jun 01
Unknown status
The Effect of Reloading Prasugrel in a Patient Who Has Already Received a Loading Dose (LD) of Clopidogrel Start of enrollment: 2010 Oct 01
Completed
Phase 4
Access Safety and Efficacy Post Endovascular Intervention Start of enrollment: 2012 Dec 01
Unknown status
Not Applicable
Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors Start of enrollment: 2013 Apr 01
Completed
Phase 1
Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor Start of enrollment: 2014 Jan 01
Unknown status
Phase 4
Safety of PZ-128 in Subjects Undergoing Non-Emergent Percutaneous Coronary Intervention Start of enrollment: 2016 May 27
Completed
Phase 2
Quantification of Binding and Neutralizing Antibody Levels in COVID-19 Vaccinated Health Care Workers Over 1 Year Start of enrollment: 2021 Jan 31
Recruiting
Roles: Principal Investigator, Contact
Multidisciplinary Approach to Reduce Cardiovascular Health Disparities Start of enrollment: 2023 Feb 06
Recruiting
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

103 citations
Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS
Usman Baber, George Dangas, Dominick J. Angiolillo, David J. Cohen, Samin K. Sharma
European Heart Journal. 2020-10-01
8 citations
Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial.
Jacek Kubica, Piotr Adamski, Diana A. Gorog, Aldona Kubica, Bernd Jilma
Cardiology Journal. 2021-09-30
594 citations
Ticagrelor with or without Aspirin in High-Risk Patients after PCI
Roxana Mehran, Usman Baber, Samin K Sharma, David J. Cohen, Dominick J. Angiolillo
The New England Journal of Medicine. 2019-09-26

Abstracts/Posters

[Board 554] Comparing Carvedilol With Metoprolol Succinate For All-Cause Mortality in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review a...
Paul Gurbel, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/18/2019
[Board 047] Point-of-Care CYP2C19 Genotype Guided Antiplatelet Therapy in Cardiac Catheterization Laboratory and Clinical Outcomes After PCI
Paul Gurbel, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Press Mentions

Sinai Center for Thrombosis Research and Drug DevelopmentJune 23rd, 2022
The GlycoMark® Test Is More Accurate Than HbA1c and Glucose for Predicting Mortality in Diabetic and Non-Diabetic COVID-19 PatientsNovember 16th, 2021
Rapid Test Study Could Help Doctors Determine Who Needs COVID-19 Booster ShotAugust 19th, 2021
Join now to see all